Scandinavian ChemoTech
Full Management and Board Subscribes to the Warrant Program Adopted by the AGM
The warrant program includes 470,000 warrants allocated to management and 690,000 to the board of directors. Both programs have been fully subscribed, underscoring the strong alignment of interests between company leadership and shareholders.
"This is a clear signal of commitment and confidence from both our board and management in the future of Scandinavian ChemoTech," said Robin Sukhia, Chairman. "The participation serves as a quality stamp for the company and reflects the shared belief in our long-term vision and growth potential."
The Strike Price for the warrants is 4,50 SEK with a subscription period between 1 September 2028 and 31 October 2028. The valuation was made by a third party using the Black and Scholes model to make the program neutral from any discounts or taxable benefits.
| Datum | 2025-06-24, kl 14:20 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!